A recent proof-of-concept study demonstrated the ability of CD98hc-redirected UniCAR T cells to eradicate radioresistant (RR) HNSCC cells in a 2D in vitro model [32]. This evidence concerns the gene SLC3A2 and head and neck squamous cell carcinoma.